Samoa Wellness Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.

Press releases published on August 17, 2026

11 hours ago

Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale

Indeterminate GlobeNewswire

11 hours ago

Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer

Indeterminate GlobeNewswire

11 hours ago

Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

11 hours ago

Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees

Indeterminate GlobeNewswire

11 hours ago

NEXGEL Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

11 hours ago

Netflix’s Voicemails for Isabelle Creator Leah McKendrick to Receive Claire's Place Foundation's 2026 Clairity Spotlight Award

Indeterminate GlobeNewswire

12 hours ago

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

Indeterminate GlobeNewswire

12 hours ago

Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub

Indeterminate GlobeNewswire

12 hours ago

InspireMD Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

12 hours ago

Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary

Indeterminate GlobeNewswire

12 hours ago

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Indeterminate GlobeNewswire

12 hours ago

SEED Therapeutics Nominated for 2026 Prix Galien USA “Best Start-Up” Award

Indeterminate GlobeNewswire

12 hours ago

Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026

Indeterminate GlobeNewswire

12 hours ago

Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies

Indeterminate GlobeNewswire

12 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

Indeterminate GlobeNewswire

12 hours ago

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD

Indeterminate GlobeNewswire

12 hours ago

Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer

Indeterminate GlobeNewswire

16 hours ago

Casa Aire Wellness Expands Hyperpigmentation Correction Treatments in Dubai From AED 250 as Year-Round UV Makes Melasma One of the City's Most Treated Skin Concerns in 2026

Indeterminate GlobeNewswire

18 hours ago

argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

Indeterminate GlobeNewswire

Aug. 17, 2026

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

Indeterminate GlobeNewswire